Similarly, Zhao et al. [27] performed a retrospective analysis of NPM1-mutated AML patients with a history of myelodysplastic syndrome (MDS) or of myelodysplastic/myeloproliferative neoplasm (MDS/MPN), (AML-MRC-H). The gene discussed is CD200; the disease is myelodysplastic syndrome.